WYNNE RINICKER: Open Payments
NPI 1730468083 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 14 payments from 8 companies in 2025. Trend: 2023 $167 · 2024 $235 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Astellas Pharma US Inc | 2 | $30 |
| Abbott Laboratories | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VRAYLAR, FARXIGA, Veozah, FREESTYLE LIBRE 3, JOURNAVX, Cologuard Collection Kit, Auvelity, SHINGRIX.
Industry payments across LA — which companies pay providers there.
